Literature DB >> 7497391

Mycobacterium abscessus infection of a Norplant contraceptive implant site.

M J Alfa1, J J Sisler, G K Harding.   

Abstract

The authors report a case of Mycobacterium abscessus infection of a subdermal levonogestrel implant (Norplant) site. The infection lasted 12 weeks and was indolent, skin manifestations were low grade and difficult to detect. Culture of exudate samples showed that M. abscessus was the only causative agent. After the implant was removed the patient's arm healed uneventfully without antimycobacterial therapy. The authors recommend that if Gram staining of apparently infected material from an implant site does not reveal a causative organism, then cultures should be done for mycobacteria and fungi. Kinyoun staining for acid-fast bacteria and calcoflour-white staining for fungi should also be performed. The implant should be removed and the patient given antimicrobial therapy as indicated. The authors emphasize the need to be aware of the potential for M. abscessus infection of implant sites and stress that appropriate microbiologic culture procedures are essential for accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497391      PMCID: PMC1487500     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  14 in total

1.  Insertion site complications during the first year of NORPLANT use.

Authors:  S L Klavon; G S Grubb
Journal:  Contraception       Date:  1990-01       Impact factor: 3.375

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 3.  Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.

Authors:  R J Wallace
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 4.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

5.  Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution.

Authors:  T J Safranek; W R Jarvis; L A Carson; L B Cusick; L A Bland; J M Swenson; V A Silcox
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

6.  Mycobacterium chelonei infection of a Broviac catheter insertion site.

Authors:  H D Engler; A Hass; D S Hodes; E J Bottone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

7.  Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California.

Authors:  P W Lowry; C M Beck-Sague; L A Bland; S M Aguero; M J Arduino; A N Minuth; R A Murray; J M Swenson; W R Jarvis
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

8.  Comparison of local signs and symptoms after the insertion of Norplant implants with and without a scalpel.

Authors:  J Díaz; J Rubin; A Faúndes; M Díaz; L Bahamondes
Journal:  Contraception       Date:  1991-09       Impact factor: 3.375

9.  Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.

Authors:  R J Wallace; D Tanner; P J Brennan; B A Brown
Journal:  Ann Intern Med       Date:  1993-09-15       Impact factor: 25.391

Review 10.  Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects.

Authors:  G L Woods; J A Washington
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr
View more
  1 in total

1.  Multisite Infection with Mycobacterium abscessus after Replacement of Breast Implants and Gluteal Lipofilling.

Authors:  Eva Rüegg; Alexandre Cheretakis; Ali Modarressi; Stephan Harbarth; Brigitte Pittet-Cuénod
Journal:  Case Rep Infect Dis       Date:  2015-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.